Varsetatug is a humanized IgG1kappa monoclonal antibody inhibitor targeting EpCAM/TROP1/CD326. Varsetatug has an antitumor activity. Varsetatug can be used for cancers such as breast, prostate and ovarian cancer research[1][2].
Molecular Weight:
(155.116 kDa)
Purity:
97
CAS Number:
[3036004-28-8]
Target:
Transmembrane Glycoprotein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted